已收盘 08-21 16:00:00 美东时间
-0.210
-6.10%
DNA X (NASDAQ:SONM) reported quarterly losses of $(0.91) per share. This is a 93.57 percent increase over losses of $(14.15) per share from the same period last year.
08-20 04:18
DNA X, Inc press release (SONM): Q2 GAAP EPS of -$0.92. The Company ended the quarter with $0.9 million. Subsequent to June 30, 2026, the Company received $5.0 million in cash from the sale of preferr...
08-20 04:18
DNA X, Inc. reported Q2 2026 financial results, highlighting $1.8 million in cash from new convertible debt and an additional $5.0 million from preferred stock sales post-quarter end. The company converted $3.1 million in outstanding notes to preferred stock, optimizing its balance sheet. With no revenue from continuing operations due to the AI trading platform being closed during the quarter, the company expects revenue to resume by late Q3 or e...
08-19 20:15
Sonim Technologies ( ($SONM) ) has provided an announcement. On June 29, 2026, ...
07-02 21:28
On June 29, 2026, DNA X, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with DNA Holdings Venture, Inc. ("DNA Holdings"), a holder of more than 5% of the Company’s outstanding capital stock and an entity associated with Scott Walker, a member of the Comp...
07-02 20:59
Gainers Astrotech (NASDAQ:ASTC) stock rose 43.4% to $50.76 during Tuesday's re...
06-03 01:06
Sonim Technologies ( ($SONM) ) has shared an update. On May 20, 2026, DNA X, In...
05-28 05:43
DNA X shares are trading lower after the company reported worse-than-expected Q...
05-21 23:34
Sonim Technologies (NASDAQ:SONM) reported quarterly earnings of $5.01 per share which missed the analyst consensus estimate of $5.04 by 0.6 percent. This is a 255.32 percent increase over earnings of $1.41 per share from
05-21 05:07
DNA X, Inc press release (SONM): FY GAAP EPS of -$11.00. "Cash Position: We ended the year with $1.3 million in cash from continuing operations. This cash plus cash proceeds from the asset sale will b...
04-15 15:41